Improved biosynthesis of heme in Bacillus subtilis through metabolic engineering assisted fed-batch fermentation.
In: Microbial Cell Factories, Jg. 22 (2023-05-18), Heft 1, S. 1-12
Online
academicJournal
Zugriff:
Background: Heme is an iron/porphyrin complex compound, widely used in the health care, food, and pharmaceutical industries. It is more advantageous and attractive to develop microbial cell factories to produce heme by fermentation, with lower production costs and environmentally more friendly procedures than those of the traditional extraction based on animal blood. In this study, Bacillus subtilis, a typical industrial model microorganism of food safety grade, was used for the first time as the host to synthesize heme. Results: The heme biosynthetic pathway was engineered as four modules, the endogenous C5 pathway, the heterologous C4 pathway, the uroporphyrinogen (urogen) III synthesis pathway, and the downstream synthesis pathway. Knockout of hemX encoding the negative effector of the concentration of HemA, overexpression of hemA encoding glutamyl-tRNA reductase, and knockout of rocG encoding the major glutamate dehydrogenase in the C5 pathway, resulted in an increase of 427% in heme production. Introduction of the heterologous C4 pathway showed a negligible effect on heme biosynthesis. Overexpression of hemCDB, which encoded hydroxymethylbilane synthase, urogen III synthase, and porphobilinogen synthase participating in the urogen III synthesis pathway, increased heme production by 39%. Knockouts of uroporphyrinogen methyltransferase gene nasF and both heme monooxygenase genes hmoA and hmoB in the downstream synthesis pathway increased heme production by 52%. The engineered B. subtilis produced 248.26 ± 6.97 mg/L of total heme with 221.83 ± 4.71 mg/L of extracellular heme during the fed-batch fermentation in 10 L fermenter. Conclusions: Strengthening endogenous C5 pathway, urogen III synthesis pathway and downstream synthesis pathway promoted the biosynthesis of heme in B. subtilis. The engineered B. subtilis strain has great potential as a microbial cell factory for efficient industrial heme production. [ABSTRACT FROM AUTHOR]
Copyright of Microbial Cell Factories is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Improved biosynthesis of heme in Bacillus subtilis through metabolic engineering assisted fed-batch fermentation.
|
---|---|
Autor/in / Beteiligte Person: | Yang, Shaomei ; Wang, Anlong ; Li, Jiachang ; Shao, Yunhang ; Sun, Fengjie ; Li, Shucheng ; Cao, Kai ; Liu, Hongliang ; Xiong, Peng ; Gao, Zhengquan |
Link: | |
Zeitschrift: | Microbial Cell Factories, Jg. 22 (2023-05-18), Heft 1, S. 1-12 |
Veröffentlichung: | 2023 |
Medientyp: | academicJournal |
ISSN: | 1475-2859 (print) |
DOI: | 10.1186/s12934-023-02077-3 |
Schlagwort: |
|
Sonstiges: |
|